-
1 Comment
FINDEX Inc is currently in a long term downtrend where the price is trading 5.3% below its 200 day moving average.
From a valuation standpoint, the stock is 89.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.3.
FINDEX Inc's total revenue rose by 42.1% to $1B since the same quarter in the previous year.
Its net income has increased by 191.4% to $88M since the same quarter in the previous year.
Based on the above factors, FINDEX Inc gets an overall score of 3/5.
| ISIN | JP3801450002 |
|---|---|
| Sector | Healthcare |
| Industry | Health Information Services |
| Exchange | TSE |
| CurrencyCode | JPY |
| PE Ratio | 16.21 |
|---|---|
| Target Price | 23.7 |
| Beta | 0.38 |
| Market Cap | 20B |
| Dividend Yield | 2.7% |
FINDEX Inc. offers medical devices in Japan. It operates through Medical Business, Public Business, and Healthtech Business segments. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big data search system, FAXde regional collaboration FAX referral management system, LIS endoscope system endoscopy department system, LIS ultrasound system ultrasound department system, ProRad RS radiology reporting system, gateway system, RemoTalkCloud, remote sharing app for medical information, C-Nys / C-Nys ME Nystagmus analysis support system, Cloud backup service security service, PiCls Medical Avenue for patient information app, PiCls On-examination online medical support system, PiCls AAdE-report electronic tracing report service, PiCls booking assistant first appointment online reservation service, PiCls connect medical institution collaboration service, WebeLi, and CocktailAI ,a generative AI for medical text generation; and DigiWorker, an RPA tool for healthcare. It also offers REMORA+Claio, an ophthalmology solution; G-QuICC DB Program, a glaucoma protocol; ENT package; DocuMaker Cloud, a medical certificate and other document creation service; REMORA Cloud, a cloud-based electronic medical record; C-Note + Claio, an ophthalmology solution; ClaioDashboard integrated viewing system; DocuMaker office, a document management system for administrative department; DocuMakerShelf, an electronic bookkeeping solution; and GAP-screener, line-of-sight analysis type perimeter for medical examination facilities. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was incorporated in 1985 and is headquartered in Chiyoda, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3649.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026